Verod Capital

Verod Capital is a Lagos-based firm operating both traditional private equity and tech-focused venture capital arms (the latter as Verod-Kepple, a joint venture with Japanese Kepple Africa Ventures), with sustainable, gender-lens investing across West African health and tech sectors. Check sizes of $5M to $25M and a stage focus on Series A through growth place Verod Capital in the institutional growth-equity range, while the venture arm operates at earlier stages. The firm has explicit AI thematic positioning in its venture activities.

The firm’s natural fit is differentiated by which arm engages. For Verod Capital’s PE arm, the right profile is a West African healthcare operator running revenue-scale care delivery, pharmaceutical, or health services businesses with audited financials and a credible growth thesis. For Verod-Kepple’s venture arm, the profile shifts to earlier-stage technology founders building digital health and tech-enabled platforms across West Africa. Founders below revenue scale should approach the venture arm; founders running scaled operations should approach the PE arm.

Geographically, Verod’s advantage is unmatched West African coverage (Nigeria, Ghana, Cote d’Ivoire) with senior operating expertise in healthcare and adjacent sectors. The firm’s gender-lens emphasis is genuine and reflected in portfolio composition and reporting practices. For West African operators, the firm is among the most credible regional partners. For non-African founders, the strategic logic is thin.

The right entry path differs by arm. For the PE arm, an investment banker leading the round or an existing growth-stage co-investor is the typical route; for the venture arm, a warm intro from a portfolio founder, a regional African VC, or a fellow Verod-Kepple co-investor is the path. Both arms read partner-led decks at institutional pace.

Caveats. The dual-arm structure means founders should be precise about which arm fits the stage and check size. African macroeconomic and FX dynamics introduce real risk; cross-border holding structures matter. The gender-lens emphasis introduces specific reporting expectations; review LP-driven constraints. The firm’s healthcare-specific portfolio is real but spread across PE and VC formats; reference calls with portfolio operators are essential. For West African healthcare operators, Verod Capital is among the most credible regional specialists; for non-African or out-of-stage founders, the fit is weaker.